| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Perspective Therapeutics, Inc. | 10%+ Owner | Common Stock | 116,773,394 | $110,934,724 | $0.9500 | 06 Mar 2024 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| CATX | Perspective Therapeutics, Inc. | 06 Mar 2024 | 1 | +$57,409,487 | 4 | 10%+ Owner | 08 Mar 2024, 11:24 |
| CATX | Perspective Therapeutics, Inc. | 22 Jan 2024 | 0 | $0 | 3 | 10%+ Owner | 01 Feb 2024, 07:56 |